Asian stocks decline on unease over vaccine development

by Jonathan Adams
Asian stocks

The Nikkei 225 dropped to 26,506.97, Hang Seng dipped to 26,761.22, the Kospi was down to 2,625.84, and S&P-ASX 200 fell to 6,592.50

Asian stock markets declined Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism.

Benchmarks in Tokyo, Hong Kong, Seoul and Sydney retreated while Shanghai gained.

Investors have been encouraged by reports of progress toward a possible vaccine. But they were uneasy after researchers questioned data that showed a candidate from the University of Oxford and AstraZeneca was 70% effective.

Market participants showed increasing signs of nervousness as data errors were revealed, said Mizuho Bank in a report.

The Nikkei 225 in Tokyo lost 0.1% to 26,506.97 and Hong Kong’s Hang Seng sank 0.2% to 26,761.22. The Shanghai Composite Index added 0.4% to 3,383.06.

The Kospi in Seoul lost less than 0.1% to 2,625.84 and Sydney’s S&P-ASX 200 fell 0.7% to 6,592.50. New Zealand and Jakarta gained while Singapore retreated.

Investors are looking forward to a possible vaccine to control the coronavirus following the deepest economic slump since the 1930s, though forecasters warn the stock market rebound might be too early to be sustained.

Those hopes were dented this week when researchers questioned how Oxford and AstraZeneca calculated the effectiveness of their vaccine. That alliance is among researchers who have reported the most progress toward a possible vaccine. The AstraZeneca CEO told Bloomberg News the company might conduct another trial.

Investors also are dismayed that U.S. states and European governments are reimposing controls on business and travel as infection rates surge.

The disease has killed more than 1.4 million people worldwide and there are 61 million confirmed cases, according to data gathered by Johns Hopkins University.



Important
This article is for information purposes only.
Please remember that financial investments may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Related News

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Know more